Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
about
Visual dysfunction in Parkinson's diseaseThe Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseThe prediagnostic phase of Parkinson's diseaseLRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Olfaction in Parkin carriers in Chinese patients with Parkinson diseaseLRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian populationThe management of gastrointestinal symptoms in Parkinson's disease.Leucine-rich repeat kinase 2 for beginners: six key questions.Nonmotor symptoms in LRRK2 G2019S associated Parkinson's diseaseDepression and Parkinson's disease: current knowledge.Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?Clinical correlations with Lewy body pathology in LRRK2-related Parkinson diseaseSleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersOlfaction in Parkinson's disease and related disorders.Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation.A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation AnalysisEffect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchEffect of dual-task interference on the hand flexibility of patients with Parkinson's disease carrying the leucine-rich repeat kinase 2 gene mutationResearch on the premotor symptoms of Parkinson's disease: clinical and etiological implications.Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulationGenetic insights into sporadic Parkinson's disease pathogenesis.LRRK2: cause, risk, and mechanism.Investigation of c9orf72 in 4 neurodegenerative disorders.Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions.Motor signs in the prodromal phase of Parkinson's disease.Lysosome-dependent pathways as a unifying theme in Parkinson's disease.Non-motor signs in Parkinson's disease: a review.The relevance of pre-motor symptoms in Parkinson's disease.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory systemThe prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.Clinical Features of LRRK2 Carriers with Parkinson's Disease.Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study.Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.Multisystem Lewy body disease and the other parkinsonian disorders.Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients
P2860
Q26740467-665CCA60-8ED3-49EC-B718-00AB52F1112EQ26744716-CFF6F0BA-DA04-4833-B676-5E319C32B884Q26768732-16A290FB-BA2F-493B-9C6C-A7F83D1853DCQ33561039-9B332C07-DE08-4AD6-8F03-9BD11F11A8A8Q33695309-38EE151F-E69E-492D-9916-B41A9D6ABCD2Q34089529-99BB6866-AB82-41C1-B900-1C97B5AE1952Q34250597-360D9598-EC38-459B-A0F8-99FBEC3D8224Q34259058-B1C56FF2-F03F-4218-94E9-DC3CCC74A17CQ34361735-31D99AC8-2572-470A-89C8-946809AE3536Q34382560-7D7E733F-D833-4936-B8C9-3EF9E8F80981Q34562789-7E408077-63BD-4993-B41A-4234ED1E5FFAQ34576193-370D5D81-27A9-4809-B4DE-B1D60F31211DQ35442728-C87B44A5-97C2-4928-9859-85535F0EA9EEQ35692655-0711F2EA-E1BE-40B7-9C5D-B4E2290B1F21Q36193915-E1BDE018-1572-44EE-B054-749C7B3D1DF6Q36198611-C0C38673-ACA6-4676-BECE-D0209DC6F704Q36379938-59D337FB-8A0E-4D17-BF97-7D6B8483C6BDQ36885946-C04CD48B-0C85-4E26-84AD-2675B9342163Q36983484-2D3757A0-DBC2-4454-88B0-9544826ADC6EQ37287403-3D171048-AF09-46CC-B739-640A9E7C998DQ37313260-F2B4BDB8-7CAA-4809-BE20-7D9E9E5ED62CQ37374203-2DDB7D44-A292-42B3-9C09-E5A061EF4CDFQ37385032-8791CCF4-921A-4FEA-85CE-AA6A78F10EB5Q37455677-03C47AD9-3396-48C4-81DD-DD69FF3AADEDQ37583402-21B8086D-7049-473B-9F0C-003801D38F52Q37635000-E417291E-3363-491C-9F0C-2079FB8248ACQ37734768-1F608300-B5FD-4CDC-B228-F6DA4EAEB229Q37955275-82FCBED6-5FB1-42FA-8640-9D88B34DDFC4Q37995956-78CF17D4-8ABD-4FB4-B943-2AD44B48CA1DQ38038561-0438EDA7-4E45-4EDF-8742-56881AEB3CBCQ38448936-C1B33196-ADD0-41A9-8F42-C77C1AAA8244Q38594857-D01B9AE0-3E05-4EAF-A1F6-11A2610BF38AQ38752945-96F7E0B5-BBF0-4212-96F2-B77E9AC2EC1AQ38859352-1A9B0DDD-46E6-4843-9C24-B553D5E41DA8Q38881337-5D86377A-F4B1-4741-8D60-1B71E8E842C2Q39206423-E66BA529-E1BB-4BB7-98C5-FFCC638C6FE5Q39366467-46C377FB-0B4D-458E-9AF0-5F7AE8B86154Q39841718-8CEDC360-E610-43B9-975E-92EF59C704D7Q40260539-4D09B1D3-5BA4-4306-B968-F8C4FA84D046Q41819059-4F2C54F5-481E-4C88-B88C-D90CDC3EC04D
P2860
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@ast
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@en
type
label
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@ast
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@en
prefLabel
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@ast
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@en
P2093
P2860
P1433
P1476
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
@en
P2093
J W Langston
K K Johansen
P2860
P304
P356
10.1212/WNL.0B013E318227042D
P407
P577
2011-07-13T00:00:00Z